Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Srinivas Ramishetti

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Nature Communications|October 31, 2018
Cell specific delivery of modified mRNA expressing therapeutic proteins to leukocytesNuphar Veiga, Meir Goldsmith, Yasmin Granot, et al.
Small (Weinheim an Der Bergstrasse, Germany)|April 7, 2021
Therapeutic Gene Silencing Using Targeted Lipid Nanoparticles in Metastatic Ovarian CancerManu Smriti Singh, Srinivas Ramishetti, Dalit Landesman-Milo, et al.
ACS Nano|January 7, 2015
Localized RNAi therapeutics of chemoresistant grade IV glioma using hyaluronan-grafted lipid-based nanoparticlesZvi R Cohen, Srinivas Ramishetti, Naama Peshes-Yaloz, et al.
Journal of the American Chemical Society|March 28, 2013
Nickel(II) dithiocarbamate complexes containing sulforhodamine B as fluorescent probes for selective detection of nitrogen dioxideYan Yan, Saarangan Krishnakumar, Huan Yu, et al.
Nature Nanotechnology|June 18, 2021
Conformation-sensitive targeting of lipid nanoparticles for RNA therapeuticsNiels Dammes, Meir Goldsmith, Srinivas Ramishetti, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 22, 2019
Leukocyte-specific siRNA delivery revealing IRF8 as a potential anti-inflammatory targetNuphar Veiga, Meir Goldsmith, Yael Diesendruck, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 14, 2024
The future of genetic medicines delivered via targeted lipid nanoparticles to leukocytesDana Tarab-Ravski, Lior Stotsky-Oterin, Aviad Elisha, et al.
Advanced Materials (Deerfield Beach, Fla.)|January 19, 2022
Dual-Targeted Lipid Nanotherapeutic Boost for Chemo-Immunotherapy of CancerSeok-Beom Yong, Srinivas Ramishetti, Meir Goldsmith, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 25, 2021
Therapeutic inhibitory RNA in head and neck cancer via functional targeted lipid nanoparticlesLiyona Kampel, Meir Goldsmith, Srinivas Ramishetti, et al.
ACS Nano|June 5, 2015
Systemic Gene Silencing in Primary T Lymphocytes Using Targeted Lipid NanoparticlesSrinivas Ramishetti, Ranit Kedmi, Meir Goldsmith, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Nature Communications|October 31, 2018
Cell specific delivery of modified mRNA expressing therapeutic proteins to leukocytesNuphar Veiga, Meir Goldsmith, Yasmin Granot, et al.
Small (Weinheim an Der Bergstrasse, Germany)|April 7, 2021
Therapeutic Gene Silencing Using Targeted Lipid Nanoparticles in Metastatic Ovarian CancerManu Smriti Singh, Srinivas Ramishetti, Dalit Landesman-Milo, et al.
ACS Nano|January 7, 2015
Localized RNAi therapeutics of chemoresistant grade IV glioma using hyaluronan-grafted lipid-based nanoparticlesZvi R Cohen, Srinivas Ramishetti, Naama Peshes-Yaloz, et al.
Journal of the American Chemical Society|March 28, 2013
Nickel(II) dithiocarbamate complexes containing sulforhodamine B as fluorescent probes for selective detection of nitrogen dioxideYan Yan, Saarangan Krishnakumar, Huan Yu, et al.
Nature Nanotechnology|June 18, 2021
Conformation-sensitive targeting of lipid nanoparticles for RNA therapeuticsNiels Dammes, Meir Goldsmith, Srinivas Ramishetti, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 22, 2019
Leukocyte-specific siRNA delivery revealing IRF8 as a potential anti-inflammatory targetNuphar Veiga, Meir Goldsmith, Yael Diesendruck, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 14, 2024
The future of genetic medicines delivered via targeted lipid nanoparticles to leukocytesDana Tarab-Ravski, Lior Stotsky-Oterin, Aviad Elisha, et al.
Advanced Materials (Deerfield Beach, Fla.)|January 19, 2022
Dual-Targeted Lipid Nanotherapeutic Boost for Chemo-Immunotherapy of CancerSeok-Beom Yong, Srinivas Ramishetti, Meir Goldsmith, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 25, 2021
Therapeutic inhibitory RNA in head and neck cancer via functional targeted lipid nanoparticlesLiyona Kampel, Meir Goldsmith, Srinivas Ramishetti, et al.
ACS Nano|June 5, 2015
Systemic Gene Silencing in Primary T Lymphocytes Using Targeted Lipid NanoparticlesSrinivas Ramishetti, Ranit Kedmi, Meir Goldsmith, et al.
Pageof 4